Mycophenolic acid - Avantec Vascular

Drug Profile

Mycophenolic acid - Avantec Vascular

Alternative Names: Mycophenolic acid-eluting stent

Latest Information Update: 12 Nov 2016

Price : $50

At a glance

  • Originator Avantec Vascular
  • Class Caproates; Fatty acids; Small molecules
  • Mechanism of Action Inosine monophosphate dehydrogenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Coronary artery restenosis

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 04 Apr 2014 Discontinued - Clinical-Phase-Unknown for Coronary artery restenosis in Brazil (Intracardiac)
  • 04 Apr 2014 Discontinued - Clinical-Phase-Unknown for Coronary artery restenosis in New Zealand (Intracardiac)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top